Nutrient Sensing, Autophagy, and Diabetic NephropathyKUME, Shinji; THOMAS, Merlin C; KOYA, Daisuke et al.Diabetes (New York, NY). 2012, Vol 61, Num 1, pp 23-29, issn 0012-1797, 7 p.Article

Turning up the heat: heat shock proteins, hypertension and cardiovascular riskTHOMAS, Merlin C; COOPER, Mark E.Journal of hypertension. 2002, Vol 20, Num 9, pp 1713-1714, issn 0263-6352Article

Identification of obesity in patients with type 2 diabetes from Australian primary care : The NEFRON-5 studyTHOMAS, Merlin C; ZIMMET, Paul; SHAW, Jonathan E et al.Diabetes care. 2006, Vol 29, Num 12, pp 2723-2725, issn 0149-5992, 3 p.Article

Blood pressure lowering for the prevention and treatment of diabetic kidney diseaseTHOMAS, Merlin C; ATKINS, Robert C.Drugs (Basel). 2006, Vol 66, Num 17, pp 2213-2234, issn 0012-6667, 22 p.Article

Post-translational modification of plant-made foreign proteins; glycosylation and beyondWEBSTER, Diane E; THOMAS, Merlin C.Biotechnology advances. 2012, Vol 30, Num 2, pp 410-418, issn 0734-9750, 9 p.Article

Glycaemic control and graft loss following renal transplantationTHOMAS, Merlin C; MATHEW, Timothy H; RUSS, Graeme R et al.Nephrology, dialysis, transplantation (Print). 2001, Vol 16, Num 10, pp 1978-1982, issn 0931-0509Article

The epidemiology of hemoglobin levels in patients with type 2 diabetesTHOMAS, Merlin C; TSALAMANDRIS, Con; MACLSAAC, Richard J et al.American journal of kidney diseases. 2006, Vol 48, Num 4, pp 537-545, issn 0272-6386, 9 p.Article

Changes in thyroxine requirements in patients with hypothyroidism undergoing renal transplantationTHOMAS, Merlin C; MATHEW, Timothy H; RUSS, Graeme R et al.American journal of kidney diseases. 2002, Vol 39, Num 2, pp 354-357, issn 0272-6386Article

Dialysis delayed is death prevented: A clinical perspective on the RENAAL studyTHOMAS, Merlin C; COOPER, Mark E; SHAHINFAR, Shahnaz et al.Kidney international. 2003, Vol 63, Num 4, pp 1577-1579, issn 0085-2538, 3 p.Article

Unrecognized Anemia in patients with diabetes: A cross-sectional surveyTHOMAS, Merlin C; MACISAAC, Richard J; TSALAMANDRIS, C. O. N et al.Diabetes care. 2003, Vol 26, Num 4, pp 1164-1169, issn 0149-5992, 6 p.Article

The assessment of kidney function by general practitioners in Australian patients with type 2 diabetes (NEFRON-2)THOMAS, Merlin C; WEEKES, Andrew J; BROADLEY, Olivia J et al.Medical journal of Australia. 2006, Vol 185, Num 5, pp 259-262, issn 0025-729X, 4 p.Article

Anemia with impaired erythropoietin response in diabetic patientsTHOMAS, Merlin C; COOPER, Mark E; TSALAMANDRIS, Con et al.Archives of internal medicine (1960). 2005, Vol 165, Num 4, pp 466-469, issn 0003-9926, 4 p.Article

Osteoprotegerin Is an Independent Predictor of Vascular Events in Finnish Adults With Type 1 DiabetesGORDIN, Daniel; SORO-PAAVONEN, Aino; THOMAS, Merlin C et al.Diabetes care. 2013, Vol 36, Num 7, pp 1827-1833, issn 0149-5992, 7 p.Article

High nephron endowment protects against salt-induced hypertensionWALKER, Kenneth A; XIAOCHU CAI; CARUANA, Georgina et al.American journal of physiology. Renal physiology. 2012, Vol 72, Num 1, issn 1931-857X, F253-F258Article

Low testosterone and anaemia in men with type 2 diabetesGROSSMANN, Mathis; PANAGIOTOPOLOUS, Sianna; SHARPE, Ken et al.Clinical endocrinology (Oxford. Print). 2009, Vol 70, Num 4, pp 547-553, issn 0300-0664, 7 p.Article

Prevalence and predictors of cardiac hypertrophy and dysfunction in patients with Type 2 diabetesSRIVASTAVA, Piyush M; CALAFIORE, Paul; MACISAAC, Richard J et al.Clinical science (1979). 2008, Vol 114, Num 3-4, pp 313-320, issn 0143-5221, 8 p.Article

Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosisFORBES, Josephine M; TEO LOON YEE, Louis; COOPER, Mark E et al.Diabetes (New York, NY). 2004, Vol 53, Num 7, pp 1813-1823, issn 0012-1797, 11 p.Article

The burden of anaemia in type 2 diabetes and the role of nephropathy: a cross-sectional auditTHOMAS, Merlin C; MACISAAC, Richard J; TSALAMANDRIS, Con et al.Nephrology, dialysis, transplantation (Print). 2004, Vol 19, Num 7, pp 1792-1797, issn 0931-0509, 6 p.Article

Osteopontin Is a Strong Predictor of Incipient Diabetic Nephropathy, Cardiovascular Disease, and All-Cause Mortality in Patients With Type 1 DiabetesGORDIN, Daniel; FORSBLOM, Carol; GROOP, Per-Henrik et al.Diabetes care. 2014, Vol 37, Num 9, pp 2593-2600, issn 0149-5992, 8 p.Article

Genetic Deletion of Cell Division Autoantigen 1 Retards Diabetes-Associated Renal InjuryZHONGLIN CHAI; AOZHI DAI; YUGANG TU et al.Journal of the American Society of Nephrology. 2013, Vol 24, Num 11, pp 1782-1792, issn 1046-6673, 11 p.Article

Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathyTAN, Adeline L. Y; SOURRIS, Karly C; FORBES, Josephine M et al.American journal of physiology. Renal physiology. 2010, Vol 67, Num 3, issn 1931-857X, F763-F770Article

HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetesGROOP, Per-Henrik; THOMAS, Merlin C; ROSENGARD-BÄRLUND, Milla et al.Diabetes care. 2007, Vol 30, Num 10, pp 2706-2707, issn 0149-5992, 2 p.Article

Appetising solutions: an edible vaccine for measlesWEBSTER, Diane E; THOMAS, Merlin C; STRUGNELL, Richard A et al.Medical journal of Australia. 2002, Vol 176, Num 9, pp 434-437, issn 0025-729XArticle

Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathyFORBES, Josephine M; COOPER, Mark E; OSICKA, Tanya M et al.Diabetes (New York, NY). 2002, Vol 51, Num 11, pp 3274-3282, issn 0012-1797, 9 p.Article

Added Value of Soluble Tumor Necrosis Factor-α Receptor 1 as a Biomarker of ESRD Risk in Patients With Type 1 DiabetesFORSBLOM, Carol; MORAN, John; THOMAS, Merlin C et al.Diabetes care. 2014, Vol 37, Num 8, pp 2334-2342, issn 0149-5992, 9 p.Article